CMA
52
-3
GOOGL
51
-2
AAL
54
3
PAYX
38
-6
MMM
44
-3
BSX
70
-3
SPG
43
-2
AZO
52
-4
BEN
26
-2
VTR
32
-3
MSI
43
-4
BK
58
-5
SYY
43
2
IBM
44
-4
PG
32
-6
ZTS
29
-5
PDCO
75
-2
HP
56
4
WDC
40
-2
SBUX
45
-3
CMA
52
-3
GOOGL
51
-2
AAL
54
3
PAYX
38
-6
MMM
44
-3
BSX
70
-3
SPG
43
-2
AZO
52
-4
BEN
26
-2
VTR
32
-3
MSI
43
-4
BK
58
-5
SYY
43
2
IBM
44
-4
PG
32
-6
ZTS
29
-5
PDCO
75
-2
HP
56
4
WDC
40
-2
SBUX
45
-3
Financhill
Back

iShares 0-5 Year High Yield Corporate Bond ETF Vs. Intra-Cellular Therapies Industry Stock Comparison

Sell
35

SHYG
iShares 0-5 Year High Yield Corporate Bond ETF

Last Price:
$42.61
Seasonality Move:
-0.83%
Sell
42

ITCI
Intra-Cellular Therapies

Last Price:
$94.86
Seasonality Move:
2.9%
Sell
35
iShares 0-5 Year High Yield Corporate Bond ETF (SHYG) is a Sell

Is iShares 0-5 Year High Yield Corporate Bond ETF a Buy, Sell or Hold?

  • The current iShares 0-5 Year High Yield Corporate Bond ETF [SHYG] share price is $42.62. The Score for SHYG is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • SHYG is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Intra-Cellular Therapies (ITCI) is a Sell

Is Intra-Cellular Therapies a Buy, Sell or Hold?

  • The current Intra-Cellular Therapies [ITCI] share price is $94.87. The Score for ITCI is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • ITCI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SHYG Stock Price Chart

What is iShares 0-5 Year High Yield Corporate Bond ETF's stock price today?

  • The iShares 0-5 Year High Yield Corporate Bond ETF share price today is $42.62
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SHYG is experiencing selling pressure, which indicates risk of future bearish movement.

ITCI Stock Price Chart

What is Intra-Cellular Therapies's stock price today?

  • The Intra-Cellular Therapies share price today is $94.87
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITCI is experiencing slight buying pressure.

SHYG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.08 Sell
Relative Strength Index (14 RSI): 43.25 Sell
Chaikin Money Flow: -953558 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (42.59 - 43.07) Sell
Bollinger Bands (100): (42.79 - 43.21) Sell

ITCI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.52 Buy
Relative Strength Index (14 RSI): 71.02 Buy
Chaikin Money Flow: 1717350 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (82.26 - 87.1) Buy
Bollinger Bands (100): (74.04 - 85.96) Buy

SHYG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 42.71 Sell
20-day SMA: 42.76 Sell
50-day SMA: 42.94 Sell
200-day SMA: 42.61 Buy
8-day EMA: 42.71 Sell
20-day EMA: 42.77 Sell
50-day EMA: 42.88 Sell
200-day EMA: 42.65 Sell

ITCI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 84.68 Buy
20-day SMA: 84.71 Buy
50-day SMA: 85.48 Buy
200-day SMA: 75.72 Buy
8-day EMA: 85.91 Buy
20-day EMA: 85.03 Buy
50-day EMA: 83.75 Buy
200-day EMA: 76.64 Buy

iShares 0-5 Year High Yield Corporate Bond ETF Earnings Growth & SHYG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.92 per share, and an increase next year of $3.25 per share.

iShares 0-5 Year High Yield Corporate Bond ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Intra-Cellular Therapies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):